• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国安徽阜阳 125 例 COVID-19 住院患者的流行病学和临床特征。

Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.

机构信息

Department of Geriatric Respiratory and Critical Care, the First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, PR China; Fuyang Infectious Disease Clinical College of Anhui Medical University, Yingzhou west Road 1088, Fuyang, Anhui 236015, PR China; Department of Respiratory and Critical Care, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, PR China.

Department of Geriatric Respiratory and Critical Care, the First Affiliated Hospital of Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, PR China; Anhui Geriatric Institute, Jixi Road 218, Hefei, Anhui 230022, PR China; Institute of Respiratory Diseases, Anhui Medical University, Jixi Road 218, Hefei, Anhui 230022, PR China.

出版信息

Int J Infect Dis. 2020 Jun;95:421-428. doi: 10.1016/j.ijid.2020.03.070. Epub 2020 Apr 11.

DOI:10.1016/j.ijid.2020.03.070
PMID:32289565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151431/
Abstract

OBJECTIVE

To investigate the epidemiological and clinical features of patients with COVID-19 in Anhui province of China.

METHOD

In this descriptive study, we obtained epidemiological, demographic, manifestations, laboratory data and radiological findings of patients confirmed by real-time RT-PCR in the NO.2 People's Hospital of Fuyang City from Jan 20 to Feb 9, 2020. Clinical outcomes were followed up to Feb 18, 2020.

RESULTS

Of 125 patients infected SARS-CoV-2, the mean age was 38.76 years (SD, 13.799) and 71(56.8%) were male. Common symptoms include fever [116 (92.8%)], cough [102(81.6%)], and shortness of breath [57(45.6%)]. Lymphocytopenia developed in 48(38.4%) patients. 100(80.0%) patients showed bilateral pneumonia, 26(20.8%) patients showed multiple mottling and ground-glass opacity. All patients were given antiviral therapy. 19(15.2%) patients were transferred to the intensive care unit. By February 18, 47(37.6%) patients were discharged and none of patients died. Among the discharged patients, the median time of length of stay was 14.8 days (SD 4.16).

CONCLUSION

In this single-center, retrospective, descriptive study, fever is the most common symptom. Old age, chronic underlying diseases and smoking history may be risk factors to worse condition. Certain laboratory inspection may contribute to the judgment of the severity of illness.

摘要

目的

调查中国安徽省 COVID-19 患者的流行病学和临床特征。

方法

在这项描述性研究中,我们获取了 2020 年 1 月 20 日至 2 月 9 日阜阳市第二人民医院通过实时 RT-PCR 确诊的患者的流行病学、人口统计学、临床表现、实验室数据和影像学结果。临床结局随访至 2020 年 2 月 18 日。

结果

在 125 例感染 SARS-CoV-2 的患者中,平均年龄为 38.76 岁(标准差 13.799),71 例(56.8%)为男性。常见症状包括发热[116 例(92.8%)]、咳嗽[102 例(81.6%)]和呼吸急促[57 例(45.6%)]。48 例(38.4%)患者出现淋巴细胞减少症。100 例(80.0%)患者表现为双侧肺炎,26 例(20.8%)患者表现为多发性斑驳和磨玻璃影。所有患者均接受抗病毒治疗。19 例(15.2%)患者转入重症监护病房。截至 2 月 18 日,47 例(37.6%)患者出院,无患者死亡。在出院患者中,中位住院时间为 14.8 天(标准差 4.16)。

结论

在这项单中心、回顾性、描述性研究中,发热是最常见的症状。高龄、慢性基础疾病和吸烟史可能是病情恶化的危险因素。某些实验室检查可能有助于判断疾病严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/c8c6e841bf85/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/f44f6e84aa48/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/954eb375ca4e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/12d7140643fe/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/c8c6e841bf85/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/f44f6e84aa48/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/954eb375ca4e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/12d7140643fe/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f2/7151431/c8c6e841bf85/gr4_lrg.jpg

相似文献

1
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.中国安徽阜阳 125 例 COVID-19 住院患者的流行病学和临床特征。
Int J Infect Dis. 2020 Jun;95:421-428. doi: 10.1016/j.ijid.2020.03.070. Epub 2020 Apr 11.
2
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study.湖北省曾都区 276 例住院新冠肺炎患者的临床特征:一项单中心描述性研究。
BMC Infect Dis. 2020 Jul 29;20(1):549. doi: 10.1186/s12879-020-05252-8.
5
Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.中国武汉以外 200 例 2019 年冠状病毒病住院患者的流行病学和临床特征:一项描述性研究。
J Clin Virol. 2020 Aug;129:104475. doi: 10.1016/j.jcv.2020.104475. Epub 2020 May 26.
6
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
7
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
8
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.
9
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.2020 年湖北省武汉市周边地区 COVID-19 的流行病学和临床特征分析。
Pharmacol Res. 2020 Jul;157:104821. doi: 10.1016/j.phrs.2020.104821. Epub 2020 Apr 30.
10
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.成都 32 例危重症和 67 例非危重症 COVID-19 的流行病学特征和临床特征。
J Clin Virol. 2020 Jun;127:104366. doi: 10.1016/j.jcv.2020.104366. Epub 2020 Apr 10.

引用本文的文献

1
Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study.阿兹夫定在中国奥密克戎毒株流行期间对住院老年 COVID-19 患者的真实世界疗效和安全性:一项回顾性队列研究。
Acta Pharm Sin B. 2025 Jan;15(1):123-132. doi: 10.1016/j.apsb.2024.12.004. Epub 2024 Dec 12.
2
Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness.伊朗西北部COVID-19发病率和死亡率的空间分析,以做好未来疫情防范准备。
Sci Rep. 2025 Mar 3;15(1):7450. doi: 10.1038/s41598-025-91246-y.
3
The impact of prenatal mental health on birth outcomes before and during the COVID-19 pandemic in Anhui, China.

本文引用的文献

1
Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China.25 例 COVID-19 死亡病例的临床特征:对中国武汉某单一医疗中心病历的回顾性研究。
Int J Infect Dis. 2020 May;94:128-132. doi: 10.1016/j.ijid.2020.03.053. Epub 2020 Apr 3.
2
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.中国 COVID-19 疫情前 50 天的传播控制措施调查。
Science. 2020 May 8;368(6491):638-642. doi: 10.1126/science.abb6105. Epub 2020 Mar 31.
3
CT Imaging and Differential Diagnosis of COVID-19.
新冠疫情前后中国安徽围孕期心理健康对母婴结局的影响
PLoS One. 2024 Aug 6;19(8):e0308327. doi: 10.1371/journal.pone.0308327. eCollection 2024.
4
Clinical Characteristics of Hospitalized Patients With COVID-19 and Their Association With the Progression to Critical Illness and Death: A Single-Center Retrospective Study From Northwestern Mexico.墨西哥西北部单中心回顾性研究:COVID-19 住院患者的临床特征及其与进展为重症和死亡的关系。
Clin Respir J. 2024 Jul;18(7):e13813. doi: 10.1111/crj.13813.
5
Investigating the spatiotemporal characteristics and medical response during the initial COVID-19 epidemic in six Chinese cities.调查六个中国城市 COVID-19 疫情初期的时空特征和医疗应对措施。
Sci Rep. 2024 Mar 25;14(1):7065. doi: 10.1038/s41598-024-56077-3.
6
IL-6 and SAA-Strong Predictors for the Outcome in COVID-19 CKD Patients.IL-6 和 SAA 是 COVID-19 合并 CKD 患者结局的强有力预测指标。
Int J Mol Sci. 2023 Dec 25;25(1):311. doi: 10.3390/ijms25010311.
7
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients.老年 COVID-19 住院患者中的多种药物治疗、潜在不适当用药和药物-药物相互作用。
BMC Geriatr. 2023 Nov 25;23(1):774. doi: 10.1186/s12877-023-04487-9.
8
Smoking and prevalence of COVID-19: Evidence from studies from January 2020 - May 2020.吸烟与2019冠状病毒病的流行情况:来自2020年1月至2020年5月研究的证据。
AIMS Public Health. 2023 Jun 19;10(3):538-552. doi: 10.3934/publichealth.2023038. eCollection 2023.
9
Pectoralis muscle area measured at T4 level is closely associated with adverse COVID-19 outcomes in hospitalized patients.T4 水平测量的胸肌面积与住院患者 COVID-19 不良结局密切相关。
J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):196-204.
10
Serum amyloid A-A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19.血清淀粉样蛋白A——新型冠状病毒肺炎相关高炎症综合征的潜在治疗靶点
Front Med (Lausanne). 2023 Mar 16;10:1135695. doi: 10.3389/fmed.2023.1135695. eCollection 2023.
CT 影像学表现与新型冠状病毒肺炎的鉴别诊断。
Can Assoc Radiol J. 2020 May;71(2):195-200. doi: 10.1177/0846537120913033. Epub 2020 Mar 4.
4
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.韩国第三代 COVID-19 感染传播者索引患者病例:应用洛匹那韦/利托那韦定量 RT-PCR 监测 COVID-19 感染肺炎的治疗。
J Korean Med Sci. 2020 Feb 17;35(6):e79. doi: 10.3346/jkms.2020.35.e79.
5
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
6
Critical care management of adults with community-acquired severe respiratory viral infection.成人社区获得性严重呼吸道病毒感染的重症监护管理。
Intensive Care Med. 2020 Feb;46(2):315-328. doi: 10.1007/s00134-020-05943-5. Epub 2020 Feb 10.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].[29例2019新型冠状病毒肺炎患者临床特征分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 6;43(0):E005. doi: 10.3760/cma.j.issn.1001-0939.2020.0005.
9
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.新型冠状病毒在武汉持续爆发中的进化及其刺突蛋白对人类传播风险的建模。
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
10
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.